Home Cart 0 Sign in  

[ CAS No. 139481-69-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 139481-69-9
Chemical Structure| 139481-69-9
Structure of 139481-69-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 139481-69-9 ]

Related Doc. of [ 139481-69-9 ]

Alternatived Products of [ 139481-69-9 ]

Product Details of [ 139481-69-9 ]

CAS No. :139481-69-9 MDL No. :MFCD09263633
Formula : C25H22N6O3 Boiling Point : -
Linear Structure Formula :- InChI Key :RBPFEPGTRLLUKI-UHFFFAOYSA-N
M.W : 454.48 Pubchem ID :15654696
Synonyms :
Chemical Name :Methyl 1-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate

Calculated chemistry of [ 139481-69-9 ]

Physicochemical Properties

Num. heavy atoms : 34
Num. arom. heavy atoms : 26
Fraction Csp3 : 0.16
Num. rotatable bonds : 8
Num. H-bond acceptors : 7.0
Num. H-bond donors : 1.0
Molar Refractivity : 126.67
TPSA : 107.81 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : Yes
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : No
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -5.9 cm/s

Lipophilicity

Log Po/w (iLOGP) : 3.72
Log Po/w (XLOGP3) : 4.47
Log Po/w (WLOGP) : 4.12
Log Po/w (MLOGP) : 3.72
Log Po/w (SILICOS-IT) : 4.15
Consensus Log Po/w : 4.04

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -5.51
Solubility : 0.0014 mg/ml ; 0.00000308 mol/l
Class : Moderately soluble
Log S (Ali) : -6.45
Solubility : 0.00016 mg/ml ; 0.000000352 mol/l
Class : Poorly soluble
Log S (SILICOS-IT) : -8.61
Solubility : 0.00000111 mg/ml ; 0.0000000024 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 3.0
Synthetic accessibility : 3.52

Safety of [ 139481-69-9 ]

Signal Word:Danger Class:4.1
Precautionary Statements:P240-P210-P241-P264-P280-P302+P352-P370+P378-P337+P313-P305+P351+P338-P362+P364-P332+P313 UN#:1325
Hazard Statements:H315-H319-H228 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 139481-69-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 139481-69-9 ]
  • Downstream synthetic route of [ 139481-69-9 ]

[ 139481-69-9 ] Synthesis Path-Upstream   1~14

  • 1
  • [ 139481-44-0 ]
  • [ 139481-69-9 ]
YieldReaction ConditionsOperation in experiment
85%
Stage #1: With sodium azide; tributyltin chloride In toluene at 110 - 115℃; for 24 h; Heating / reflux
Stage #2: With acetic acid In methanol; water; toluene at 15 - 20℃; for 1 h;
Preparation of 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- lH-benzimidazole-7-carboxylic acid methyl ester To 2-ethoxy-1-[[2'-cyano [l, 1'-biphenyl] -4-yl] methyl]-lH-benzimidazole-7- carboxylic acid methyl ester of Formula IV (310 g) in toluene (2.48 L) added tributyltin chloride (737 g) and sodium azide (146 g) and tetrabutyl ammonium bromide (31 g). The resultant mass was slowly heated to 110°C and maintained for 24 hours at 110-115°C. The reaction was monitored by TLC and after completion of reaction, the reaction mass was cooled to 15°C. Added methanol (3.1 L) and water (2.17 L) to the reaction mass followed by addition of acetic acid (930 g). The resultant mixture was stirred at 15-20°C for 1 hour to allow separation of the product. Charged toluene (1.24 L) at 15-20°C and filtered the reaction mass. Washed the cake thoroughly with water (0.93 L) to completely remove the acidity (until the pH of the washing is between about 5.5 to about 7.0). Washed the cake with toluene (0.62 L) and suck dried. Air dried the product at 50-55°C to afford the title compound. Yield: 290 g (85percent)
Reference: [1] Journal of Medicinal Chemistry, 1993, vol. 36, # 15, p. 2182 - 2195
[2] Patent: WO2005/51929, 2005, A1, . Location in patent: Page/Page column 18
[3] Patent: US2009/203920, 2009, A1, . Location in patent: Page/Page column 4
[4] Patent: EP1420016, 2004, A1, . Location in patent: Page 19
[5] Patent: WO2009/157001, 2009, A2, . Location in patent: Page/Page column 3
[6] Patent: WO2006/15134, 2006, A1, . Location in patent: Page/Page column 16-17
[7] Patent: US2018/155326, 2018, A1, . Location in patent: Paragraph 0035
  • 2
  • [ 139481-44-0 ]
  • [ 139481-69-9 ]
YieldReaction ConditionsOperation in experiment
100% With sodium nitrite In ethanol; hexane; ethyl acetate; toluene EXAMPLE 5
Methyl 2-ethoxy-1-[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methylbenzimidazole-7-carboxylate
A mixture of 13.0 g of methyl 1-(2'-cyanobiphenyl-4-yl)methyl-2-ethoxybenzimidazole-7-carboxylate, 47.1 g of trioctyltin azide (tri-n-octyltin azide) and 60 ml of toluene was refluxed at 125° C. for 31 hours.
After cooling, the reaction mixture was concentrated.
To the concentrate was added 56 ml of ethanol as well as an aqueous solution of sodium nitrite (7.7 g/28 ml) and the mixture was adjusted to pH 5 with concentrated hydrochloric acid.
Then, 31 ml of ethyl acetate was added.
The mixture was further adjusted to pH 1.1 with concentrated hydrochloric acid, diluted with 20 ml of n-hexane and adjusted to pH 3.3 with 1N aqueous sodium hydroxide solution.
The crystals were separated, washed with ethyl acetate/n-hexane mixture (1:3) and dried to provide 14.56 g of methyl 2-ethoxy-1-[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methylbenzimidazole-7carboxylate.
Yield 100percent. 1 H NMR (CDCl3) δ: 1.42 (3H, t), 3.56 (3H, s), 4.27 (2H, q), 5.54 (2H, s), 6.70 (2H, d), 6.78-6.95 (4H, m), 7.28-7.33 (1H, m), 7.40 (1H, dd), 7.56-7.66 (2H, m), 8.02-8.06 (1H, m)
IR(KBr): 1720, 1618, 1548, 1476, 1432, 1390, 1354, 1324, 1284, 1222, 1134, 1042, 872, 840, 820, 780, 756 cm-1.
Reference: [1] Patent: US5484955, 1996, A,
  • 3
  • [ 21606-04-2 ]
  • [ 139481-69-9 ]
Reference: [1] Journal of Medicinal Chemistry, 1993, vol. 36, # 15, p. 2182 - 2195
[2] Patent: WO2011/145100, 2011, A1,
  • 4
  • [ 73833-13-3 ]
  • [ 139481-69-9 ]
Reference: [1] Journal of Medicinal Chemistry, 1993, vol. 36, # 15, p. 2182 - 2195
[2] Patent: WO2011/145100, 2011, A1,
  • 5
  • [ 603-11-2 ]
  • [ 139481-69-9 ]
Reference: [1] Journal of Medicinal Chemistry, 1993, vol. 36, # 15, p. 2182 - 2195
[2] Patent: WO2011/145100, 2011, A1,
  • 6
  • [ 57113-90-3 ]
  • [ 139481-69-9 ]
Reference: [1] Journal of Medicinal Chemistry, 1993, vol. 36, # 15, p. 2182 - 2195
[2] Patent: WO2011/145100, 2011, A1,
  • 7
  • [ 136304-78-4 ]
  • [ 139481-69-9 ]
Reference: [1] Journal of Medicinal Chemistry, 1993, vol. 36, # 15, p. 2182 - 2195
[2] Patent: WO2011/145100, 2011, A1,
  • 8
  • [ 139481-28-0 ]
  • [ 139481-69-9 ]
Reference: [1] Journal of Medicinal Chemistry, 1993, vol. 36, # 15, p. 2182 - 2195
[2] Patent: WO2011/145100, 2011, A1,
  • 9
  • [ 856414-36-3 ]
  • [ 139481-69-9 ]
Reference: [1] Journal of Medicinal Chemistry, 1993, vol. 36, # 15, p. 2182 - 2195
  • 10
  • [ 139481-38-2 ]
  • [ 139481-69-9 ]
Reference: [1] Journal of Medicinal Chemistry, 1993, vol. 36, # 15, p. 2182 - 2195
  • 11
  • [ 150058-27-8 ]
  • [ 139481-69-9 ]
Reference: [1] Patent: CN107056757, 2017, A,
  • 12
  • [ 124750-51-2 ]
  • [ 139481-69-9 ]
Reference: [1] Patent: CN107056757, 2017, A,
  • 13
  • [ 139481-69-9 ]
  • [ 139481-59-7 ]
YieldReaction ConditionsOperation in experiment
95%
Stage #1: With sodium hydroxide; water In methanol at 78 - 80℃; for 1 h;
Stage #2: With acetic acid In ethyl acetate at 10 - 15℃;
To the product obtained in Step A) (350 g) dissolved in methanol (1.17 L) was added sodium hydroxide solution (93 g in 1.17 L water). The reaction mass was heated to reflux at 78-80°C and maintained for 1 hour. After completion of reaction, methanol was completely removed under vacuum at 40-45°C and to the residue was added ethyl acetate (2. 8 L) and water (3.50 L) at room temperature. Stirred the mixture for about 1 hour at 25- 30°C and allowed to settle for 15 minutes. Separated the layers and pH of the aqueous layer was adjusted to 4-5 with acetic acid (about 450 g) at 10-15°C. The precipitated product was filtered and washed twice with water (2 x 0.7 L) and suck dried. The wet cake was air dried at room temperature for 2 hours and then at 50-55°C to afford the title compound. Yield: 323 g (95percent)
90% at 10 - 70℃; To 80.0 grams (0.176 moles) of methyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl] benzimidazole-7-carboxylate, were added 265 ml ofmethanol, 535 ml of water, and 21.1 grams of sodium hydroxide, below 10°C, andthe mixture was heated to 70°C and maintained until the reaction completed. Themethanol was distilled off completely under reduced pressure, and the residuewas cooled to 10°C. The pH of the residue was adjusted to 2 with aqueoushydrochloric acid solution. The precipitated compound was filtered, washed withwater and dried at 60-70°C to get 70.0 grams (90percent) of 2-ethoxy-1-[[2'-(1 H-tetrazol-5-yl)biphenyl-4-yl]-methyl]benzimidazole-7-carboxylicacid.
82% at 68 - 72℃; for 1 - 2 h; Industry scale An aqueous sodium hydroxide solution (73 kg/826L) was added to the wet MET (369.6 kg) obtained in Reference Example 9, and the mixture was stirred at 68 to 72 °C for 1 to 2 hours. The reaction solution was cooled, and washed twice with methylene chloride (486 kg) and once with toluene (366 L). Methanol (1437 L) was added to the aqueous layer, the pH was adjusted to 7.0 +/-0.5 with concentrated hydrochloric acid (about 35 L). Activated charcoal (11kg) was added, followed by stirring for about 30 minutes. The activated charcoal was filtered off, and concentrated hydrochloric acid (about 20L) was added until the solution became cloudy, followed by stirring at 25 +/-5°C for about 1 hour. Water (487 L) was added, and the pH was adjusted to 3.5 +/-0.3 with concentrated hydrochloric (about 85 L). After stirring at 24 to 30°C for about 30 minutes, water (687 L) was added, and the mixture was cooled to 10°C or lower, and stirred for about 1 hour. The crystals were separated, washed with water (412 L) and then acetone (427 L), ground, and dried to give 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylic acid (200kg, 82.0percent). mp.183-185°C 1NMR (200MHz, DMSO-d6) δ: 1.38(3H,t), 4.58(2H,q), 5.63(2H,s), 6.97(4H.q), 7.17(1H,t), 7.47-7.68(6H,m) IR (KBr) cm-1:1710, 1550, 1480, 1430, 1280, 1240, 1040, 760
Reference: [1] Patent: WO2005/51929, 2005, A1, . Location in patent: Page/Page column 18
[2] Patent: WO2006/15134, 2006, A1, . Location in patent: Page/Page column 17
[3] Journal of Medicinal Chemistry, 1993, vol. 36, # 15, p. 2182 - 2195
[4] Patent: EP1420016, 2004, A1, . Location in patent: Page 19
[5] Patent: US2009/203920, 2009, A1, . Location in patent: Page/Page column 4
[6] Patent: WO2009/157001, 2009, A2, . Location in patent: Page/Page column 4
[7] Patent: WO2011/145100, 2011, A1, . Location in patent: Page/Page column 7
[8] Patent: US2018/155326, 2018, A1, . Location in patent: Paragraph 0035
  • 14
  • [ 139481-69-9 ]
  • [ 139481-72-4 ]
Reference: [1] Patent: WO2011/145100, 2011, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 139481-69-9 ]

Aryls

Chemical Structure| 170791-09-0

[ 170791-09-0 ]

1-(((Cyclohexyloxy)carbonyl)oxy)ethyl 2-ethoxy-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate

Similarity: 0.84

Chemical Structure| 139481-72-4

[ 139481-72-4 ]

2-Ethoxy-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylic acid

Similarity: 0.79

Chemical Structure| 147403-65-4

[ 147403-65-4 ]

Methyl 2-ethoxy-1-((2'-(N-hydroxycarbamimidoyl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate

Similarity: 0.72

Chemical Structure| 139481-44-0

[ 139481-44-0 ]

Methyl 1-((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate

Similarity: 0.67

Chemical Structure| 139481-41-7

[ 139481-41-7 ]

Ethyl 1-((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate

Similarity: 0.66

Ethers

Chemical Structure| 170791-09-0

[ 170791-09-0 ]

1-(((Cyclohexyloxy)carbonyl)oxy)ethyl 2-ethoxy-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate

Similarity: 0.84

Chemical Structure| 139481-72-4

[ 139481-72-4 ]

2-Ethoxy-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylic acid

Similarity: 0.79

Chemical Structure| 147403-65-4

[ 147403-65-4 ]

Methyl 2-ethoxy-1-((2'-(N-hydroxycarbamimidoyl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate

Similarity: 0.72

Chemical Structure| 139481-44-0

[ 139481-44-0 ]

Methyl 1-((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate

Similarity: 0.67

Chemical Structure| 139481-41-7

[ 139481-41-7 ]

Ethyl 1-((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate

Similarity: 0.66

Esters

Chemical Structure| 170791-09-0

[ 170791-09-0 ]

1-(((Cyclohexyloxy)carbonyl)oxy)ethyl 2-ethoxy-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate

Similarity: 0.84

Chemical Structure| 147403-65-4

[ 147403-65-4 ]

Methyl 2-ethoxy-1-((2'-(N-hydroxycarbamimidoyl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate

Similarity: 0.72

Chemical Structure| 139481-44-0

[ 139481-44-0 ]

Methyl 1-((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate

Similarity: 0.67

Chemical Structure| 139481-41-7

[ 139481-41-7 ]

Ethyl 1-((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate

Similarity: 0.66

Chemical Structure| 147403-52-9

[ 147403-52-9 ]

Methyl 2-ethoxy-1-((2'-(5-oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate

Similarity: 0.66

Related Parent Nucleus of
[ 139481-69-9 ]

Benzimidazoles

Chemical Structure| 170791-09-0

[ 170791-09-0 ]

1-(((Cyclohexyloxy)carbonyl)oxy)ethyl 2-ethoxy-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate

Similarity: 0.84

Chemical Structure| 139481-72-4

[ 139481-72-4 ]

2-Ethoxy-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylic acid

Similarity: 0.79

Chemical Structure| 147403-65-4

[ 147403-65-4 ]

Methyl 2-ethoxy-1-((2'-(N-hydroxycarbamimidoyl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate

Similarity: 0.72

Chemical Structure| 139481-44-0

[ 139481-44-0 ]

Methyl 1-((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate

Similarity: 0.67

Chemical Structure| 139481-41-7

[ 139481-41-7 ]

Ethyl 1-((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate

Similarity: 0.66